Skip to main content

BIOX · Bioceres Crop Solutions Corp.

Track BIOX — free
$0.21 -0.01 (-5.41%) At close · Nov 13
Market Cap
$13.40M
Shares
63.82M
Volume · Nov 13 85.89K Avg daily vol (3M) 311.99K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.21 Open$0.22 Day$0.21–0.23 52W close$0.20–1.72 Avg vol 30d209K Short int458K · 0.7% of shares · 1.7d Short vol44% Last earningsSep 15, 2026 DataJan 2020–Nov 2026

Up next

Dec 23, 2026 Est · unconfirmed · in 5 wks

Latest documents

2026
Oct 30
Annual report 20-F FY2026, ended Jun 30
Pro Farm foreclosure drives $181.5 million loss

Bioceres Crop Solutions Corp. reported a $181.5 million loss from discontinued operations for the year ended June 30, 2026, compared with US$9.7 million in 2025, primarily driven by the Pro Farm Foreclosure.

Revenue $238.28M ▼ 17.7% Net loss $263.94M Diluted EPS -$4.06
Read from the MD&A section
2 source passages
The loss from discontinued operations for the year ended June 30, 2026 totaled $181.5 million compared to a loss of US$9.7 million in the year ended June 30, 2025. The increase of US$171.8 million was primarily driven by the Pro Farm Foreclosure. Open the document at this passage
Sep 21
Current report 6-K
Current report

Bioceres Crop Solutions Corp. says the New York Supreme Court granted plaintiffs’ damages motion, awarding amounts sought, per diem interest from July 23, 2026 until judgment, and $1.4 million in costs and attorneys’ fees; defendants plan to appeal.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$248.74M
Trailing 12 months
Net income (TTM)
−$56.37M
Trailing 12 months
Revenue growth YoY
-25.3%
Year over year
Operating margin
1.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.9%
Year over year · more shares
Price change (1Y)
-87.7%
Trailing year
Short interest
0.7%
Latest settlement · 1.7 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −50%
below
Price vs 50-day avg −32%
below
RSI (14) 39
neutral
MACD trend Positive
52-week position 0%
near low
Momentum
relative strength
Very Weak
1-month return −24%
trailing
6-month return −50%
trailing
YTD return −84%
this year
Relative strength −50%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Distributing
23 of 30 funds reported for Sep 30 · net -182.4K sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.72% of shares out · ▼ -46.3% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
30 holders — near 3-yr low, contrarian setup
Squeeze score 30
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 99%
annualized · 1-yr
Max drawdown −88%
past year
ATR 16.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Sep 15, 2026
fiscal year 27 and beyond
Gross margins 40%
fiscal year 28
Total SG&A as a percent of revenues 23%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−50% Bearish
Price vs 50-day avg
−32% Bearish
RSI (14)
39 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Distributing
23 of 30 funds reported for Sep 30 · net -182.4K sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.72% of shares out · ▼ -46.3% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
30 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $2
vs 200-day avg -50% vs 50-day avg -32%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Agricultural Inputs — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BIOX
Bioceres Crop Solutions Corp.
this stock
$13.40M -84.0% — — 0.7%
NTR
Nutrien Ltd.
$33.78B +15.4% — — 1.8%
CF
CF Industries Holdings, Inc.
$18.30B +61.7% +19.3% 8.9 6.1%
YARIY
Yara International ASA
$10.87B +4.7% — — 0.0%
MOS
Mosaic Co
$6.97B -9.0% +8.4% — 11.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
30
% held
12.9%
Reported
23 of 30
Top holder
Solel Partners LP
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
458.1K
Days to cover
1.7d
Change
-394.5K sh
View
Short Volume
Short vol %
44%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
46
Value
$17
As of
Sep 29, 2026
View
Off-Exchange
Off-exchange %
58.6%
Week of
Oct 5, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
20-F
Filed
Oct 30, 2026
This year
11

Bioceres Crop Solutions Corp. reported a $181.5 million loss from discontinued operations for the year ended June 30, 2026, compared with US$9.7 million in 2025, primarily driven by the Pro Farm Foreclosure.

View
Exempt Offerings
Offering
$15.0M
Filed
Nov 25, 2020
View
Earnings & Events
Webcasts
Last webcast
Sep 15, 2026
View
Investor Relations
Latest news
Bioceres Crop Solutions Reports F…
Published
Nov 11, 2026
View

Performance

5D 20D 120D MTD YTD
BIOX -10.3% -23.8% -49.5% +1.0% -84.0%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -12.9% -22.6% -50.0% +1.1% -94.6%
Key facts CIK 1769484 CUSIP G1117K114 13F (30d) 33 filings 19 filers Visit website Investor relations